Brain Involvement in Neuromyelitis Optica Spectrum Disorders

被引:85
|
作者
Chan, Koon Ho [1 ,2 ,3 ]
Tse, C. T. [1 ]
Chung, C. P. [1 ]
Lee, Raymand L. C. [1 ]
Kwan, J. S. C. [1 ,2 ]
Ho, P. W. L. [1 ,3 ]
Ho, J. W. M. [1 ]
机构
[1] Univ Hong Kong, Dept Med, Queen Mary Hosp, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China
[2] Univ Hong Kong, Neuroimmunol & Neuroinflammat Res Lab, Queen Mary Hosp, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China
[3] Univ Hong Kong, Res Ctr Heart Brain Hormone & Hlth Aging, Queen Mary Hosp, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China
关键词
INFLAMMATORY DEMYELINATING DISORDERS; RESONANCE-IMAGING ABNORMALITIES; ANTI-AQUAPORIN-4; ANTIBODY; MULTIPLE-SCLEROSIS; DIAGNOSTIC-CRITERIA; CLINICAL-COURSE; WATER CHANNEL; IGG; NMO; RITUXIMAB;
D O I
10.1001/archneurol.2011.249
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Neuromyelitis optica spectrum disorders (NMOSDs) are severe inflammatory demyelinating disorders of the central nervous system. Brain involvement is increasingly recognized. Objective: To study brain involvement in NMOSDs among Hong Kong Chinese patients. Design: Retrospective study of patients with NMOSDs. Setting: Tertiary medical center in Hong Kong. Patients: Thirty-four Hong Kong Chinese patients with NMOSDs of 2 years or longer were recruited. Interventions: Brain and spinal cord magnetic resonance imaging was performed during NMOSD attacks and was repeated yearly for the first 3 years. Main Outcome Measures: We evaluated clinical features of NMOSDs associated with brain involvement and brain lesions on magnetic resonance imaging. Results: Among 34 patients with NMOSDs of 2 years or longer, 20 (59%) had brain involvement. The mean age at onset among these 20 patients was 45.6 years (age range, 19-67 years); 18 were women. Eleven patients (32% of all the patients with NMOSDs) had clinical manifestation of brain involvement, 19 patients (56%) had brain abnormalities on magnetic resonance imaging consistent with inflammatory demyelination, and 2 patients (6%) fulfilled criteria for multiple sclerosis. Clinical manifestation of brain involvement included the following: trigeminal neuralgia; vomiting, vertigo, ataxia, dysphagia, and tetraparesis from lesions around the third and fourth ventricles and aqueduct; homonymous hemianopia, aphasia, hemiparesis, and cognitive impairment from extensive hemispheric white matter lesions; and ataxia, diplopia, hiccups, facial sensory loss, internuclear ophthalmoplegia, hemisensory loss, and hemiparesis from other lesions in the midbrain, pons, cerebellar peduncles, and medulla. Eight patients (24%) developed brainstem encephalitis clinically, and brainstem encephalitis was the initial clinical manifestation in 6 patients (18%). Brain abnormalities on magnetic resonance imaging were detected in brainstem in 15 patients (44%), hemispheric periventricular white matter in 7 patients (21%), deep white matter in 7 patients (21%), corpus callosum in 4 patients (12%), subcortical white matter in 3 patients (9%), thalamus in 2 patients (6%), hypothalamus in 1 patient (3%), basal ganglia in 1 patient (3%), internal capsule in 1 patient (3%), periaqueductal gray matter in 1 patient (3%), and around the third and fourth ventricles in 1 patient (3%); large confluent lesions were detected in 2 patients (6%). Conclusion: Brain involvement manifesting clinically as brainstem encephalitis is common among Hong Kong Chinese patients with NMOSDs.
引用
收藏
页码:1432 / 1439
页数:8
相关论文
共 50 条
  • [31] Neuromyelitis optica spectrum disorders: profile of a cohort according to the 2015 diagnostic criteria
    Uribe-San Martin, Reinaldo
    Ciampi, Ethel
    Galilea, Antonia
    Sandoval, Patricio
    Miranda, Hector
    Mellado, Patricio
    Pablo Cruz, Juan
    Huete, Isidro
    Carcamo, Claudia
    REVISTA DE NEUROLOGIA, 2017, 65 (05) : 193 - 202
  • [32] Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders
    Jacob, Anu
    McKeon, Andrew
    Nakashima, Ichiro
    Sato, Douglas Kazutoshi
    Elsone, Liene
    Fujihara, Kazuo
    de Seze, Jerome
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2013, 84 (08): : 922 - 930
  • [33] History of neuromyelitis optica spectrum disorders, development of the diagnostic critera
    Nytrova, P.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2020, 83 : S5 - S10
  • [34] Diagnosis of neuromyelitis optica (NMO) spectrum disorders: is MRI obsolete?
    Downer, Jonathan James
    Leite, Maria Isabel
    Carter, Ranjana
    Palace, Jacqueline
    Kueker, Wilhelm
    Quaghebeur, Gerardine
    NEURORADIOLOGY, 2012, 54 (04) : 279 - 285
  • [35] Soluble biomarkers for Neuromyelitis Optica Spectrum Disorders: a mini review
    Rodin, Rachel E.
    Chitnis, Tanuja
    FRONTIERS IN NEUROLOGY, 2024, 15
  • [36] Neuromyelitis optica spectrum disorders with unevenly clustered attack occurrence
    Akaishi, Tetsuya
    Nakashima, Ichiro
    Takahashi, Toshiyuki
    Abe, Michiaki
    Ishii, Tadashi
    Aoki, Masashi
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2020, 7 (01):
  • [37] Clinical Spectrum and Treatment of Neuromyelitis Optica Spectrum Disorders: Evolution and Current Status
    Sato, Douglas Kazutoshi
    Lana-Peixoto, Marco Aurelio
    Fujihara, Kazuo
    de Seze, Jerome
    BRAIN PATHOLOGY, 2013, 23 (06) : 647 - 660
  • [38] Immunobiology of neuromyelitis optica spectrum disorders
    Cuervo, Daissy Liliana Mora
    Hansel, Gisele
    Sato, Douglas Kazutoshi
    CURRENT OPINION IN NEUROBIOLOGY, 2022, 76
  • [39] Treatment of Neuromyelitis Optica Spectrum Disorders
    Chan, Koon-Ho
    Lee, Chi-Yan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (16)
  • [40] Treatment of neuromyelitis optica spectrum disorders
    Romeo, Andrew R.
    Segal, Benjamin M.
    CURRENT OPINION IN RHEUMATOLOGY, 2019, 31 (03) : 250 - 255